Table 2.
Comparative analysis of all measured variables for the EG and the CG at the initial assessment.
| Parameter | Group | Med | IQR | Min | Max | Sk. | Z | p | r |
|---|---|---|---|---|---|---|---|---|---|
| EPIC-26 (overall urinary difficulties) | CG | 2 | 2.5 | 1 | 5 | 0.64 | −0.14 | 1 | 0.02 |
| EG | 2 | 3 | 1 | 5 | 0.4 | ||||
| EPIC-26 (incontinence subscale) | CG | 9 | 0 | 7 | 10 | −1.24 | −0.14 | 1 | 0.02 |
| EG | 9 | 0 | 6 | 10 | −2.05 | ||||
| EPIC-26 (irritation/ obstruction subscale) | CG | 4 | 4 | 0 | 9 | 0.38 | 0.6 | 1 | 0.1 |
| EG | 2 | 5 | 0 | 10 | 0.73 | ||||
| EPIC-26 (vitality or hormonal symptom) | CG | 2 | 3.5 | 0 | 8 | 0.71 | 1.38 | 1 | 0.24 |
| EG | 1 | 4 | 0 | 7 | 0.7 | ||||
| EPIC-26 (bowel domain) | CG | 4 | 5.5 | 1 | 8 | 0.17 | 2.24 | 0.2 | 0.38 |
| EG | 1 | 0 | 0 | 14 | 2.46 | ||||
| EPIC-26 (sexual symptom) | CG | 19 | 2 | 11 | 24 | −0.54 | −1.93 | 0.371 | 0.33 |
| EG | 22 | 6 | 10 | 25 | −1.1 | ||||
| BDI-II | CG | 5 | 4 | 0 | 17 | 1.1 | −0.51 | 1 | 0.09 |
| EG | 5 | 8 | 0 | 20 | 0.77 | ||||
| myostatin concentration | CG | 91.91 | 24.33 | 65.28 | 169.76 | 0.94 | −3.83 | <0.001 | 0.66 |
| EG | 146.02 | 49.28 | 99.38 | 188.62 | −0.14 |
EG: experimental group; CG: control group; Min: minimum; Max: maximum; Med: median; IQR: interquartile range; Sk: skewness, Z: Z statistic; r: r statistic; p: significance level.